Skip to content

   Pharma Publications

Neuropsychopharmacology
  • Brain and cardiovascular responses to acute stress in remitted and recurrent late-life depression
    Published on 2025-02-05
    10 months ago
  • N-acetylcysteine for youth cannabis use disorder: randomized controlled trial main findings
    Published on 2025-02-04
    10 months ago
  • Correction: Neuropsychopharmacology Volume 50 Issue 2
    Published on 2025-01-30
    10 months ago
  • Childhood family environment and μ-opioid receptor availability in vivo in adulthood
    Published on 2025-01-30
    10 months ago
  • Neuroactive steroid biosynthesis during pregnancy predicts future postpartum depression: a role for the 3α and/or 3β-HSD neurosteroidogenic enzymes?
    Published on 2025-01-29
    10 months ago
  • Endocannabinoid contributions to the perception of socially relevant, affective touch in humans
    Published on 2025-01-21
    11 months ago
  • Correction: Quantifying VMAT2 target occupancy at effective valbenazine doses and comparing to a novel VMAT2 inhibitor: a translational PET study
    Published on 2025-01-21
    11 months ago
« Previous 1 … 31 32 33 34 35 … 143 Next »
Journal of Psychopharmacology
  • Effects of stress-related neuromodulators on amygdala and hippocampus resting state functional connectivity
    Published on 2024-06-21
    1 year ago
  • Developing the Open Psychedelic Evaluation Nexus consensus measures for assessment of supervised psilocybin services: An e-Delphi study
    Published on 2024-06-18
    1 year ago
  • Pivotal role of orexin signaling in the posterior paraventricular nucleus of the thalamus during the stress-induced reinstatement of oxycodone-seeking behavior
    Published on 2024-06-18
    1 year ago
  • Is microdosing a placebo? A rapid review of low-dose LSD and psilocybin research
    Published on 2024-06-15
    1 year ago
  • The pseudoscience of lithium and suicide: Reanalysis of a misleading meta-analysis
    Published on 2024-06-12
    1 year ago
  • Esketamine combined with a mindfulness-based intervention for individuals with alcohol problems
    Published on 2024-06-12
    1 year ago
  • Cognitive impairment in schizophrenia is associated with prefrontal–striatal functional hypoconnectivity and striatal dopaminergic abnormalities
    Published on 2024-06-10
    1 year ago
« Previous 1 … 31 32 33 34 35 … 134 Next »
European Neuropsychopharmacology
  • The clinical perspective on late-onset depression in European real-world treatment settings
    Published on 2024-04-28
    2 years ago
  • Diving into the precision psychiatry debate: How deep can we go?
    Published on 2024-04-27
    2 years ago
  • Lithium response in bipolar disorder: Epigenome-wide DNA methylation signatures and epigenetic aging
    Published on 2024-04-25
    2 years ago
  • Lithium versus anticonvulsants and the risk of physical disorders – Results from a comprehensive long-term nation-wide population-based study emulating a target trial
    Published on 2024-04-25
    2 years ago
  • Sex representation in mental health research
    Published on 2024-04-24
    2 years ago
  • Overcoming the barriers to identifying and managing treatment-resistant schizophrenia and to improving access to clozapine: A narrative review and recommendation for clinical practice
    Published on 2024-04-24
    2 years ago
  • The role of anxiety and insomnia in the relationship between COVID-19 perseverative cognition and depression: Parallel and serial mediation analyses
    Published on 2024-04-21
    2 years ago
« Previous 1 … 31 32 33 34 35 … 153 Next »

   Pharma Pub